These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28740175)

  • 1. Genetic and functional characterization of disease associations explains comorbidity.
    Rubio-Perez C; Guney E; Aguilar D; Piñero J; Garcia-Garcia J; Iadarola B; Sanz F; Fernandez-Fuentes N; Furlong LI; Oliva B
    Sci Rep; 2017 Jul; 7(1):6207. PubMed ID: 28740175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathway networks generated from human disease phenome.
    Cirincione AG; Clark KL; Kann MG
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):75. PubMed ID: 30255817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
    Hu YS; Xin J; Hu Y; Zhang L; Wang J
    Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway Analysis Incorporating Protein-Protein Interaction Networks Identified Candidate Pathways for the Seven Common Diseases.
    Lin PL; Yu YW; Chung RH
    PLoS One; 2016; 11(9):e0162910. PubMed ID: 27622767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease networks. Uncovering disease-disease relationships through the incomplete interactome.
    Menche J; Sharma A; Kitsak M; Ghiassian SD; Vidal M; Loscalzo J; Barabási AL
    Science; 2015 Feb; 347(6224):1257601. PubMed ID: 25700523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GUILDify v2.0: A Tool to Identify Molecular Networks Underlying Human Diseases, Their Comorbidities and Their Druggable Targets.
    Aguirre-Plans J; Piñero J; Sanz F; Furlong LI; Fernandez-Fuentes N; Oliva B; Guney E
    J Mol Biol; 2019 Jun; 431(13):2477-2484. PubMed ID: 30851278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis for identification of shared markers from various functional cells/tissues for rheumatoid arthritis.
    Xia W; Wu J; Deng FY; Wu LF; Zhang YH; Guo YF; Lei SF
    Immunogenetics; 2017 Feb; 69(2):77-86. PubMed ID: 27812736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge-based analysis of genetic associations of rheumatoid arthritis to inform studies searching for pleiotropic genes: a literature review and network analysis.
    Zheng W; Rao S
    Arthritis Res Ther; 2015 Aug; 17(1):202. PubMed ID: 26253105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of comorbid diseases using weighted geometric embedding of human interactome.
    Akram P; Liao L
    BMC Med Genomics; 2019 Dec; 12(Suppl 7):161. PubMed ID: 31888634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway-specific protein domains are predictive for human diseases.
    Shim JE; Kim JH; Shin J; Lee JE; Lee I
    PLoS Comput Biol; 2019 May; 15(5):e1007052. PubMed ID: 31075101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Align human interactome with phenome to identify causative genes and networks underlying disease families.
    Wu X; Liu Q; Jiang R
    Bioinformatics; 2009 Jan; 25(1):98-104. PubMed ID: 19010805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of disease comorbidity through hidden molecular mechanisms.
    Ko Y; Cho M; Lee JS; Kim J
    Sci Rep; 2016 Dec; 6():39433. PubMed ID: 27991583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data.
    Zhao X; Luan YZ; Zuo X; Chen YD; Qin J; Jin L; Tan Y; Lin M; Zhang N; Liang Y; Rao SQ
    Genomics Proteomics Bioinformatics; 2016 Dec; 14(6):349-356. PubMed ID: 27965104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities of Psoriasis - Exploring the Links by Network Approach.
    Sundarrajan S; Arumugam M
    PLoS One; 2016; 11(3):e0149175. PubMed ID: 26966903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network analysis and juvenile idiopathic arthritis (JIA): a new horizon for the understanding of disease pathogenesis and therapeutic target identification.
    Donn R; De Leonibus C; Meyer S; Stevens A
    Pediatr Rheumatol Online J; 2016 Jul; 14(1):40. PubMed ID: 27411317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways.
    Zeidán-Chuliá F; Gürsoy M; Neves de Oliveira BH; Özdemir V; Könönen E; Gürsoy UK
    Front Cell Infect Microbiol; 2015; 5():102. PubMed ID: 26793622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated genomics identifies convergence of ankylosing spondylitis with global immune mediated disease pathways.
    Uddin M; Codner D; Hasan SM; Scherer SW; O'Rielly DD; Rahman P
    Sci Rep; 2015 May; 5():10314. PubMed ID: 25980808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect-specific analysis of pathogenic SNVs in human interactome: Leveraging edge-based network robustness.
    Hongzhu Cui ; Korkin D
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2929-2932. PubMed ID: 28268927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.